CVE-2008-4003
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD...
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD Edwards EnterpriseOne 8.48.18 and 8.49.14 allows remote attackers to affect confidentiality via unknown vectors.
Exploit likelihood
What each source reports
NVD Score used
4.3
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD Edwards EnterpriseOne 8.48.18 and 8.49.14 allows remote attackers to affect confidentiality via unknown vectors.
- Record
CVE-2008-4003- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:P/I:N/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD Edwards EnterpriseOne 8.48.18 and 8.49.14 allows remote attackers to affect confidentiality via unknown vectors.
- Record
CVE-2008-4003- Updated
- 2026-11-02
EUVDEUVD-2008-3988 No score
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD Edwards EnterpriseOne 8.48.18 and 8.49.14 allows remote attackers to affect confidentiality via unknown vectors.
- Record
EUVD-2008-3988- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-2fxq-9xq8-p8r9 No score
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD...
Unspecified vulnerability in the PeopleTools component in Oracle PeopleSoft Enterprise and JD Edwards EnterpriseOne 8.48.18 and 8.49.14 allows remote attackers to affect confidentiality via unknown vectors.
- Record
GHSA-2fxq-9xq8-p8r9- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2008-4003 is a medium vulnerability (CVSS 4.3) in Oracle Jd Edwards Enterpriseone, published October 14, 2008. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.15%, the 67th percentile. No source names a fixed version.